The largest database of trusted experimental protocols

26 protocols using phosphate buffered saline (pbs)

1

Peanut Extract Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
The peanut extract was prepared as previously described by Pi et al. (2015[22 (link)]). Raw peanuts were lightly blanched at 100 °C for 3 min and pulverized using a BioPulverizer (Biospec Products, Inc. Bartlesville, OK, USA). Pulverized peanuts were then mixed with phosphate buffered saline (Roche, Indianapolis, IN, USA) at a 1 kg:4 L ratio. A homogenizer (OMNI GLH) was used to further homogenize the peanut-PBS mixture. The mixture was stirred overnight at 4 °C, then centrifuged for 30 minutes at 100 x g at room temperature. The aqueous fraction was centrifuged for 30 more minutes at 100 x g at room temperature to remove residual lipids. The remaining aqueous fraction, or “peanut extract”, was collected and stored at -80 °C until use. A Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA) was used to determine the protein concentration. The extract was stored so that each aliquot was thawed only once prior to use.
+ Open protocol
+ Expand
2

Peanut Extract Immunogen Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
A peanut extract was prepared in order to provide an immunogen that would elicit an IgE response upon injection. For this purpose, a peanut extract was prepared according to the method of deJonge et al. [9 (link)] with minor modifications: Raw peanuts were lightly blanched at 100°C for 3 min, pulverized using a BioPulverizer (Biospec Products, Inc. Bartlesville, OK, USA) and mixed with phosphate buffered saline (Roche, Indianapolis, IN, USA) at a 1kg:4L ratio. A homogenizer (OMNI GLH) was used to further homogenize the peanut-PBS mixture. The mixture was stirred overnight at 4°C, then centrifuged for 30 min at 100 x g at room temperature. The aqueous fraction was centrifuged for 30 more min at 100 x g at room temperature to remove the residual lipids. The remaining aqueous fraction, or “peanut extract”, was collected and stored at -80°C until use. The protein concentration was determined with the Pierce BCA Protein Assay Kit (Thermo Scientific, Rockford, IL, USA) according to manufacturer’s instructions. The extract was stored so that each aliquot was thawed only once prior to use.
+ Open protocol
+ Expand
3

Microglia Activation and Receptor Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
KIT C and KIT H were synthesized as described previously [17 (link)] by the Karlsruher Institute for Technology (KIT), Institute of Organic Chemistry, dissolved in DMSO (Merck KGaA, Darmstadt, Germany) and used in final concentrations of 0.1–25 µM. The GPR55 agonist O-1602 and GPR55 antagonist ML 193 (both from Cayman Chemicals, Ann Arbor, MI, USA, distributed by BioMol, Hamburg, Germany) were dissolved in DMSO and used in final concentrations of 5 µM (O-1602) and 25 µM (ML 193). Human interleukin (IL)-1β (100,000 U/mL in phosphate buffered saline (PBS)) was purchased from Roche Diagnostics (Manheim, Germany) and was used at a final concentration of 10 U/mL for the experiments. 5 mg/mL lipopolysaccharide (LPS) from Salmonella typhimurium (Sigma-Aldrich GmbH, Taufkirchen, Germany) was dissolved in PBS as stock and diluted with distilled water for a final concentration of 10 ng/mL in primary microglia cultures.
Figure 9 shows the chemical structure of KIT C and KIT H that were already introduced in a previous paper [17 (link)], as well as the structures of O-1602 and ML 193 obtained from the manufacturer’s (Cayman Chemicals, Ann Arbor, MI, USA) website.
+ Open protocol
+ Expand
4

Permanent Coronary Ligations and Proliferation Markers

Check if the same lab product or an alternative is used in the 5 most similar protocols
Permanent coronary artery ligations were performed as described previously.19 (link) Osmotic mini-pumps (Alzet #2002; Cupertino, California) containing BrdU (16 mg/ml in phosphate buffered saline; Roche, Indianapolis, Indiana) or EdU (13.14 mg/ml in 10% DMSO) were implanted as described.20 (link)
+ Open protocol
+ Expand
5

Dextran Binding Interaction Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Dextran (MW = 75 kDa)
was purchased from Thermo Fisher Scientific, dialysis membranes from
Spectrum, and recombinant cytokines from PeproTech. For ITC and SPR
samples, phosphate-buffered saline (PBS; Roche Diagnostics GmbH, Mannheim,
Germany); sterile dimethyl sulfoxide (DMSO) USP >99.9% (Stemsol,
Protide
Pharmaceuticals Inc., IL, USA); C1 carboxymethylated, matrix-free
chip series S (BR100535); and the Amine Coupling Kit (BR100050) were
obtained from Cytiva. Other solvents and general reagents were purchased
from TCI America or Sigma-Aldrich and used as received unless otherwise
indicated. 1H NMR spectra were acquired at 500 MHz (Varian
Unity Inova), and chemical shifts are reported relative to the residual
solvent peak.
+ Open protocol
+ Expand
6

MTT Assay for Cell Viability

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cell viability was detected by the MTT assay. 1 × 104 THP-1 cells were inoculated in 96-well plates for 24 h and incubated with 20 μL MTT reagent which dissolved in phosphate buffer (PBS) (Roche, Basel, Switzerland, 5 mg/ml) at 37 °C for 4 h. The culture medium was removed and 150 μL dimethyl sulfoxide (DMSO, Roche, Basel, Switzerland) was added. A microplate reader (Olympus, Tokyo, Japan) was used to evaluate cell viability with absorbance of 490 nm.
+ Open protocol
+ Expand
7

Adipogenic Differentiation of SVF Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
SAT and VAT were dissected and then digested in digestion medium (collagenase D 1.5 unit/mL and dispase II 2.4 unit/mL in sterilized phosphate-buffered saline [PBS]; Roche, Mannheim, Germany) at 37℃ for approximately 30 minutes, which was stopped by adding complete medium (Dulbecco's modified Eagle's medium [GIBCO, ThermoFisher Scientific, Waltham, MA USA]/F12 containing 10% foetal bovine serum [FBS] and 100 µg/mL penicillin and 0.1 mg/mL streptomycin). After centrifugation, the cell suspension was filtered through a cell strainer (50 to 70 µm diameter) and centrifuged at 700×g for 10 minutes. The SVF cells were re-suspended in complete medium and plated on collagen-coated six-well plates. After reaching 95% to 97% confluence, the cells were initiated to differentiate via addition of induction medium (complete medium with addition of insulin [GIBCO] 5 µg/mL, indomethacin 125 µM, dexamethasone 2 µg/mL, and 3-isobutyl-1-methylxanthine [IBMX; Sigma-Aldrich, St. Louis, MO, USA]). After 48 hours of differentiation, the medium was changed to maintenance medium (complete medium with addition of insulin 5 µg/mL, GIBCO) for 24 hours to complete one differentiation cycle. The SVF cells underwent two adipogenic differentiation cycles.
+ Open protocol
+ Expand
8

Lcp1 Immunostaining in Zebrafish Larvae

Check if the same lab product or an alternative is used in the 5 most similar protocols
For Lcp1 immunostaining, larvae were anesthetized with 200 μg/ml tricaine and then immediately fixated in 4% paraformaldehyde in PBS (phosphate-buffered saline, pH 7.2) for 16 h at 4 °C. After fixation, the larvae were rinsed in PBS-DTx (phosphate-buffered saline with 0.5% DMSO and 0.3% Triton X-100) and treated with proteinase K (10 μg/ml in PBS-DTx; Roche) for 10 min at 37 °C. The larvae were blocked in 5% normal sheep serum (Sigma-Aldrich) in PBS-DTx for 2 h at room temperature, incubated with Lcp1/L-Plastin antibody (a gift from Dr. Anna Huttenlocher, University of Wisconsin, USA) in 1:1000 dilution at 4 °C overnight and subsequently incubated with Alexa-488 conjugated secondary antibody (1:200; Invitrogen) for 2 h at room temperature. The larvae were washed with PBS-DTx and stored at 4 °C until imaging.
+ Open protocol
+ Expand
9

Spermatozoa DNA Extraction Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Spermatozoa pellets of samples in the Method 1 group (Fig 1.1) were defrosted at room temperature and washed in PBS (Roche), followed by centrifugation at 400 x g for 10 min and supernatant removal. Cells were resuspended in lysis buffer (Tris-HCL 25 mM, pH 8.1, EDTA 5 mM, SDS 1%, proteinase K 0.4 mg/mL) and incubated at 55 °C for 6 h with gentle agitation. Lysates (Fig 1.2) were phenol-chloroform extracted and the DNA recovered by ethanol precipitation in the presence of ammonium acetate. DNA precipitates were resuspended in TE buffer (Tris-HCl 10mM, pH 8.1, EDTA 1mM). RNA remaining in the solution was digested with RNase A (20μg/mM) (Qiagen) at 37 °C for 20 min. Processed DNA samples were stored in TE buffer at -80 °C (Fig 1.3).
+ Open protocol
+ Expand
10

Isolation of Stromal Vascular Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Stromal vascular cells (SVCs) were isolated from samples using a well-established collagenase-based method [13 (link), 14 (link)]. In brief, harvested epididymal fat pads were soaked in PBS (Gibco) and 2% BSA (Gibco), after which they were pulverized into pieces 1-2 mm in diameter. Next, collagenase (Sigma) and DNase I (Roche) were added to the samples, after which the reactions were shaken for 20 min at 37°C with the addition of 2% BSA/PBS and 5 mM EDTA. After filtration through 100 μM nylon mesh (BD Science), the mixtures were centrifuged at 1000 rpm for 3 min to remove the supernatants. The pellets at the bottom were mixed with PBS and 2% FBS (Sigma). The samples were filtered again using the 100 μm nylon mesh to remove unnecessary tissue. After centrifugation at 200 rpm for 10 min, SVCs were obtained from the bottom of the samples.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!